We were interested in the recent publication of Albrecht et al. on body mass index (BMI) distribution in rheumatoid arthritis (RA) \[[@CR1]\]. According to this analysis of three large cohorts, the majority of patients with RA are overweight \[[@CR1]\]. Low remission rates and common metabolic syndrome indicate that the increasing BMI in RA should be treated, but weight loss may not be the solution as it has been linked to increased mortality \[[@CR2]\]. Working on nutritional status in RA, we had the opportunity to compare the body composition analysis (DEXA) and physical activity levels recorded over 3 days with Actimeters (SenseWear Arm Bands, Body Media, Stanford, CA, USA) in overweight versus normal-weight patients. We feel that our results may help orientate management despite the obesity paradox in RA.

As depicted in Table [1](#Tab1){ref-type="table"}, the main characteristics of the patients (age and gender) and their disease (duration, DAS28-ESR, and use of corticosteroids) were similar in the overweight and normal subjects. The rates of rheumatoid cachexia and osteopenia were dramatically reduced in overweight patients. Over the whole group, BMI were positively related to bone mass (*r* = +0.29, *p* \< 0.05) and the rachis T scores (*r* = +0.36, *p* \< 0.01). The overweight patients had lower levels of physical activity, and BMI was negatively related to these levels: metabolic equivalent tasks (METs) (*r* = --0.60, *p* \< 0.001) and daily duration of physical activity (*r* = --0.41, *p* \< 0.005).Table 1Characteristics of patients with rheumatoid arthritis and who were overweight or obese (*N* = 27) as compared to patients of normal weight (*N* = 29)Normal weightOverweight or obese*p*Gender (% men)20%21%NSAge (years)56 ± 1258 ± 9NSDuration of rheumatoid arthritis (years)6.9 ± 8.37.2 ± 6.6NSDAS28-ESR3.7 ± 1.74.1 ± 2.0NSTreated by corticosteroids (%)65%53%NSNutritional status Body mass index (kg/m^2^)22.1 ± 2.230.5 ± 6.9\<0.0001 Fat (%)32.1 ± 10.238.0 ± 8.2\<0.05 Fat-free mass index (kg/m^2^)15.2 ± 1.718.6 ± 2.7\<0.001 Metabolic syndrome (%)10.3%39.3%\<0.05 Rheumatoid cachexia (%)34.5%3.7%\<0.01Bone status Bone mass (g)1978 ± 3652223 ± 398\<0.05 Rachis T score--1.1 ± 1.30.0 ± 1.4\<0.005 Osteopenic, rachis (%)66%24%\<0.005 Femoral neck, T score--1.3 ± 1.2--0.6 ± 1.2\<0.05 Osteopenic, femoral (%)74%40%\<0.05Actimetry Metabolic equivalent tasks1.52 ± 0.321.24 ± 0.25\<0.005 Duration of physical activity (min/day)109 ± 9959 ± 71\<0.05*DAS28-ESR* Disease Activity Score in 28 joints-erythrocyte sedimentation rate, *NS* not significant

The body composition analysis of our overweight patients shows that some of their nutritional characteristics should be preserved by therapeutic intervention: less rheumatoid cachexia, that is known to reduce life expectancy, and less osteopenia, whereas the risk of fractures is doubled in RA \[[@CR3]\]. The reduced levels of physical activity in overweight RA patients has been reported using questionnaires \[[@CR4]\], but to our knowledge this has not yet been demonstrated with more objective actimetry measurements as we have performed. Improving these low levels of activity should be beneficial for the metabolic syndrome of overweight patients. Exercise is also considered beneficial for osteoporosis and for rheumatoid cachexia. The main limitation of interventions on physical activity is their modest results in terms of weight loss \[[@CR5]\], while mortality may be increased by frank and unintentional weight loss in RA \[[@CR2]\].
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See related research by Albrecht et al., <http://arthritis-research.biomedcentral.com/articles/10.1186/s13075-016-1043-9>
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